维普期刊资源整合服务平台（V6.5）

76篇 您的检索式：作者名="Javle"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Primary Esophageal Lymphoma: Case Series and Review of the Literature显示文摘	Krishdeep Singh Chadha MD Francisco J. Hernandez-Ilizaliturri MD Milind Javle MD	2006	Digestive Diseases and Sciences2006，，1：	3
2	Ramucirumab: successfully targeting angiogenesis in gastric cancer 显示文摘	JAVLE M SMYTH EC CHAU I	2014	Clin Cancer Res2014，20，23：	1
3	Celecoxib and mucosal protection:translation from an anmial model to a phase I clinical trial of celecoxib,irinotecan,and 5-fluorouracil显示文摘	Javle MM Cao S Durrani FA	2007	Clin Cancer Res2007，13，3：	1
4	Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer 显示文摘	Tanaka M Javle M Dong X	2010	Cancer2010，116，22：	1
5	Regular aspirin use and esophageal cancer risk显示文摘	Jayaprakash V Menezes RJ Javle MM	2006	Int J Cancer2006，119，1：	1
6	Pilot study of gefitinib,oxaliplatin, and radiotherapy for esophageal adenocarcinoma: tissue effect pre- dicts clinical response 显示文摘	Javle M Pande A Iyer R	2008	Am J Clin Oncol2008，31，4：	1
7	Inhibition of the mammalian target of rapamycin (roTOR) in advanced pancreatic cancer: results of two phase II studies显示文摘	Javle MM Shroff RT Xiong H	2010	BMC Cancer2010，10，：	1
8	Activated Akt and Erk Expression and Survival After Surgery in Pancreatic Carcinoma显示文摘	Krishdeep S. Chadha MD Thaer Khoury MD Jihnhee Yu PhD Jennifer D. Black PhD John F. Gibbs MD Boris W. Kuvshinoff MD Dongfeng Tan MD Michael G. Brattain PhD Milind M. Javle MD	2006	Annals of Surgical Oncology2006，，7：	1
9	Palliation of malignant dysphagia in esophageal cancer: a literature -based review显示文摘	Javle M Ailawadhi S Yang GY	2006	J Support Oncol2006，4，37：	1
10	Cholangiocarcinoma: an endoscopist's perspective显示文摘	Atiq M Javle M Dang S	2010	Expert Rev Gastroenterol Hepatol2010，4，5：	1
11	Inhibition of the mammalian target of rapamycin (roTOR) in advanced pan- creatic cancer: results of two phase Ⅱ studies 显示文摘	Javle MM Shroff RT Xiong H	2010	BMC Cancer2010，10，：	1
12	A phase IIstudy of weekly docetaxel in comhindtion with capecitabine in advanced gastric and gastroesophageal adenocar-cinomas 显示文摘	Lo SSX Khorana AA Javle M	2010	Oncology2010，78，：	1
13	Grading of benign prostatic obstruction can predict the outcome of transurethral prostatectomy显示文摘	Javle P Jenkins SA Machin DG	1998	J Urol1998，160，5：	1
14	Randomized phase Ⅱ study of gemcitabine (G) plus anti-IGF-1R antibody MK-0646, G plus erlotinib (E) plus MK-0646 and G plus E for advanced pancreatic cancer显示文摘	JAVLE MM VARADHACHARY GR FOGELMAN DR	2011	J Clin Oncol2011，，：	1
15	Comprehensive analysis of potential predictive biomarkers for insulin-like growth factor type-1 receptor (IGF-1 R) targeted therapy in pancreatic cancer 显示文摘	SHROFF RT JAVLE MM LI D	2011	J Clin Oncol2011，，：	1
16	Prostate abscess:a rare complication of brachytherapy for prostate cancer显示文摘	Gilmore P E Baird A D Javle P M	2009	Ann R Coil Surg Engl2009，91，4：	1
17	Radical cystectomy: defining the threshold for a surgeon to achieve optimum outcomes显示文摘	McCabe JE Jibawi A Javle PM	2007	Postgrad Med J2007，83，982：	1
18	Neoadjuvant therapy for gastric cancer显示文摘	Chadha MK Kuvshinoff BW Javle MM	2005	Oncology ( Williston Park)2005，19，9：	1
19	Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies显示文摘	Javle MM Shroff RT Xiong H	2010	BMC Cancer2010，，10：	1
20	A muhi-center phase Ⅱ study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroe- sophageal junction carcinoma 显示文摘	Brell JM Krishnamurthi SS Javle M	2009	Cancer Chemother Pharmaco12009，63，5：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示